Search

everythinglearnresearchcommunity

for

Search:↓

Scarless healing is complex and influenced by genetics and environment, while better understanding could improve scar treatment.

Dermal papilla cells help skin stem cells grow into hair.

Entospletinib effectively prevents eye and skin GVHD in mice.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

Stem cell therapies may help improve symptoms and quality of life for people with epidermolysis bullosa.

Regenerative medicine in Malaysia shows promise for treating diseases but faces ethical and safety challenges.

iNKT cells help develop and maintain healthy skin in young mice.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Rejuvenating self-repair mechanisms could improve organ recovery in regenerative medicine.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Activating TERT in mice skin boosts hair growth by waking up hair follicle stem cells.

Macrophage issues cause chronic wound inflammation, but therapies can help.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

The 2012 criteria are better for diagnosing atypical lupus cases.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.